EXHIBIT 1 SEGMENTATION OF GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 NUMBER OF BIOSIMILAR PRODUCT AUTHORIZATIONS IN US AND EUROPE
EXHIBIT 4 ESTIMATED PATENT EXPIRATIONS OF BIOLOGICS ACROSS VARIOUS REGIONS
EXHIBIT 5 BIOSIMILAR PIPELINE BY PHASES OF DEVELOPMENT (2013 & 2020)
EXHIBIT 6 IMPACT OF RISE IN PRODUCT LAUNCHES & APPROVALS OF BIOSIMILARS
EXHIBIT 7 LAUNCHES & APPROVALS OF BIOSIMILARS IN US (2015–2021)
EXHIBIT 8 BIOSIMILAR PRODUCT AUTHORIZATIONS IN US AND EUROPE
EXHIBIT 9 LAUNCHES OF NEW & UPCOMING BIOSIMILARS IN US
EXHIBIT 10 IMPACT OF FAVORABLE POLICIES ENCOURAGING USE OF BIOSIMILARS
EXHIBIT 11 IMPACT OF PATENT EXPIRATIONS OF BLOCKBUSTER BRANDED BIOLOGIC DRUGS
EXHIBIT 12 ESTIMATED PATENT EXPIRATIONS OF BIOLOGICS ACROSS VARIOUS REGIONS
EXHIBIT 13 IMPACT OF RISING POTENTIAL OF BIOSIMILARS IN EMERGING MARKETS
EXHIBIT 14 GROWTH OF BIOSIMILAR SHARES IN EMERGING MARKETS
EXHIBIT 15 IMPACT OF FAVORABLE PATIENT DEMOGRAPHICS WITH RISE IN DISEASE BURDEN
EXHIBIT 16 GLOBAL STATISTICS OF MAJOR AUTOIMMUNE DISEASES (2021)
EXHIBIT 17 ESTIMATED PERCENTAGE OF MAJOR CANCERS WORLDWIDE (2022)
EXHIBIT 18 IMPACT OF ROBUST PIPELINE OF BIOSIMILARS BOOSTING CONTRACT MANUFACTURING
EXHIBIT 19 BIOSIMILAR PIPELINE BY PHASES OF DEVELOPMENT (2013 & 2020)
EXHIBIT 20 PIPELINE OF BIOSIMILARS IN VARIOUS COUNTRIES OR REGIONS
EXHIBIT 21 TOP BIOSIMILAR COMPANIES WITH THEIR TOTAL & PIPELINE BIOSIMILAR PRODUCTS
EXHIBIT 22 IMPACT OF RISING INVESTMENTS FOR DEVELOPING BIOSIMILARS
EXHIBIT 23 IMPACT OF HIGH COST OF BIOLOGICS & SURGE IN DEMAND FOR BIOSIMILARS
EXHIBIT 24 CHANGE IN PRICES AFTER INTRODUCTION OF BIOSIMILAR ACCESSIBLE MARKET
EXHIBIT 25 IMPACT OF QUALITY CONTROL AND SUPPLY CHAIN ISSUES WITH CONTRACT MANUFACTURING
EXHIBIT 26 MAJOR BARRIERS TO EFFECTIVE VACCINE HANDLING AND STORAGE
EXHIBIT 27 IMPACT OF COMPLEXITIES & LIMITATIONS INVOLVED IN MANUFACTURING BIOSIMILARS
EXHIBIT 28 IMPACT OF HIGH COST OF ESTABLISHING BIOMANUFACTURING FACILITIES
EXHIBIT 29 TOP 10 GLOBAL MANUFACTURING HUBS
EXHIBIT 30 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 31 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE
EXHIBIT 32 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION
EXHIBIT 33 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT
EXHIBIT 34 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION
EXHIBIT 35 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY
EXHIBIT 36 FIVE FORCES ANALYSIS 2021
EXHIBIT 37 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 38 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE
EXHIBIT 39 NUMBER OF BIOSIMILARS IN PIPELINE DISTRIBUTED BY PHASE AND PRODUCTION TECHNOLOGY 2019
EXHIBIT 40 VARIOUS CELL LINE EXPRESSION SYSTEMS OFFERED BY CONTRACT MANUFACTURERS
EXHIBIT 41 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE: INCREMENTAL GROWTH
EXHIBIT 42 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE: ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL MAMMALIAN BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 ORIGINATORS AND PRODUCTS OF MAMMALIAN-BASED BIOSIMILAR TARGETS DISTRIBUTED BY PHASE
EXHIBIT 45 GLOBAL MAMMALIAN BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 GLOBAL NON-MAMMALIAN BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 ORIGINATORS AND PRODUCTS OF MICROBIAL-BASED BIOSIMILAR TARGETS DISTRIBUTED BY PHASE
EXHIBIT 49 GLOBAL NON-MAMMALIAN BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 51 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 52 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION
EXHIBIT 53 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION: INCREMENTAL GROWTH
EXHIBIT 54 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION: ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL COMMERCIAL BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL COMMERCIAL BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 58 GLOBAL RESEARCH BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL RESEARCH BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 61 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 62 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT
EXHIBIT 63 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 64 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY FINISHED DOSAGE FORM: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY FINISHED DOSAGE FORM 2021–2027 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 68 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY ACTIVE PHARMACEUTICAL INGREDIENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY ACTIVE PHARMACEUTICAL INGREDIENT 2021–2027 ($ MILLION)
EXHIBIT 70 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 71 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 72 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION
EXHIBIT 73 EMA- & FDA-APPROVED BIOSIMILARS BY THERAPEUTIC AREA (2019)
EXHIBIT 74 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION: INCREMENTAL GROWTH
EXHIBIT 75 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION: ABSOLUTE GROWTH
EXHIBIT 76 GLOBAL ONCOLOGY BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 EXPIRED PATENTS OF ONCOLOGY BIOLOGIC DRUGS IN US & EUROPE
EXHIBIT 78 FDA-APROVED BIOSIMILARS FOR ONCOLOGY TREATMENT
EXHIBIT 79 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY ONCOLOGY 2021–2027 ($ MILLION)
EXHIBIT 80 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 81 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY BLOOD DISORDERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 82 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY BLOOD DISORDERS 2021–2027 ($ MILLION)
EXHIBIT 83 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 84 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INFLAMMATORY & AUTOIMMUNE DISORDERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 85 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INFLAMMATORY & AUTOIMMUNE DISORDERS 2021–2027 ($ MILLION)
EXHIBIT 86 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 87 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY OTHER INDICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 88 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY OTHER INDICATIONS 2021–2027 ($ MILLION)
EXHIBIT 89 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 90 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 91 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY
EXHIBIT 92 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY: KEY COUNTRIES (2021)
EXHIBIT 93 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 94 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 95 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET: KEY COUNTRIES (2021)
EXHIBIT 96 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 97 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 98 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 99 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 100 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 101 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 103 GERMANY BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 104 FRANCE BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 105 UK BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 106 ITALY BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 107 SPAIN BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET: KEY COUNTRIES (2021)
EXHIBIT 109 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 110 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 111 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 112 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 113 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 114 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 115 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 116 US BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 117 CANADA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 118 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET: KEY COUNTRIES (2021)
EXHIBIT 119 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 120 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 121 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 123 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 124 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 125 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 126 CHINA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 127 SOUTH KOREA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 128 INDIA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 129 JAPAN BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 130 AUSTRALIA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 131 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET: KEY COUNTRIES (2021)
EXHIBIT 132 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 133 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 134 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 135 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 136 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 137 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 138 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 139 BRAZIL BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 140 MEXICO BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 141 ARGENTINA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 142 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET: KEY COUNTRIES (2021)
EXHIBIT 143 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 144 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 145 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 146 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 147 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 148 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 149 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 150 TURKEY BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 151 SAUDI ARABIA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 152 UAE BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 153 SOUTH AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET 2021–2027 ($ MILLION)
EXHIBIT 154 LONZA: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 155 LONZA: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 156 LONZA: TOTAL R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 157 LONZA: REVENUE BY GEOGRAPHIC REGION 2020–2021 ($ MILLION)
EXHIBIT 158 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: TOTAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 159 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ BILLION)
EXHIBIT 160 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: TOTAL R&D EXPENDITURE 2019–2021 ($ BILLION)
EXHIBIT 161 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE BY GEOGRAPHIC REGION 2019–2021 ($ BILLION)
EXHIBIT 162 CATALENT: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 163 FUJIFILM: TOTAL REVENUE 2018–2020 ($ BILLION)
EXHIBIT 164 FUJIFILM: REVENUE BY BUSINESS SEGMENT 2019–2020 ($ BILLION)
EXHIBIT 165 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 166 THERMO FISHER SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 167 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 168 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 PATENT EXPIRATION OF MAJOR BIOLOGICS BY THERAPEUTIC AREA
TABLE 4 NUMBER OF BIOSIMILARS IN DEVELOPMENTAL PIPELINE (2017 & 2019)
TABLE 5 BIOSIMILARS APPROVED BY FDA & EMA (BY INDICATION)
TABLE 6 LONZA: MAJOR PRODUCT OFFERINGS
TABLE 7 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: MAJOR PRODUCT OFFERINGS
TABLE 8 CATALENT: MAJOR PRODUCT OFFERINGS
TABLE 9 FUJIFILM: MAJOR PRODUCT OFFERINGS
TABLE 10 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 11 ABBVIE: MAJOR SERVICE OFFERINGS
TABLE 12 ABZENA: MAJOR SERVICE OFFERINGS
TABLE 13 AGC BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 14 ALCAMI: MAJOR SERVICE OFFERINGS
TABLE 15 ALMAC GROUP: MAJOR SERVICE OFFERINGS
TABLE 16 AVID BIOSERVICES: MAJOR SERVICE OFFERINGS
TABLE 17 BIOCON: MAJOR SERVICE OFFERINGS
TABLE 18 ELEMENT MATERIALS TECHNOLOGY: MAJOR SERVICE OFFERINGS
TABLE 19 EUROFINS SCIENTIFIC: MAJOR SERVICE OFFERINGS
TABLE 20 FRESENIUS KABI: MAJOR SERVICE OFFERINGS
TABLE 21 GOODWIN BIOTECHNOLOGY: MAJOR SERVICE OFFERINGS
TABLE 22 KEMWELL: MAJOR SERVICE OFFERINGS
TABLE 23 MABXIENCE: MAJOR SERVICE OFFERINGS
TABLE 24 MERCK KGAA: MAJOR SERVICE OFFERINGS
TABLE 25 MIDAS PHARMA: MAJOR SERVICE OFFERINGS
TABLE 26 NOVARTIS AG: MAJOR SERVICE OFFERINGS
TABLE 27 PFIZER: MAJOR SERVICE OFFERINGS
TABLE 28 RENTSCHLER BIOPHARMA: MAJOR SERVICE OFFERINGS
TABLE 29 SAMSUNG BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 30 WUXI BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 31 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 32 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 (%)
TABLE 33 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 34 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 (%)
TABLE 35 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 36 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 (%)
TABLE 37 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 38 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 (%)
TABLE 39 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 40 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 (%)
TABLE 41 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 42 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SOURCE 2021–2027 (%)
TABLE 43 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 ($ MILLION)
TABLE 44 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 (%)
TABLE 45 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 ($ MILLION)
TABLE 46 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 (%)
TABLE 47 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 ($ MILLION)
TABLE 48 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 (%)
TABLE 49 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 ($ MILLION)
TABLE 50 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 (%)
TABLE 51 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 ($ MILLION)
TABLE 52 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 (%)
TABLE 53 MIDDLE EAST AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 ($ MILLION)
TABLE 54 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021–2027 (%)
TABLE 55 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 56 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 (%)
TABLE 57 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 58 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 (%)
TABLE 59 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 60 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 (%)
TABLE 61 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 62 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 (%)
TABLE 63 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 64 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 (%)
TABLE 65 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 66 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY PRODUCT 2021–2027 (%)
TABLE 67 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 ($ MILLION)
TABLE 68 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 (%)
TABLE 69 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 ($ MILLION)
TABLE 70 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 (%)
TABLE 71 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 ($ MILLION)
TABLE 72 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 (%)
TABLE 73 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 ($ MILLION)
TABLE 74 APAC BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 (%)
TABLE 75 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 ($ MILLION)
TABLE 76 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 (%)
TABLE 77 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 ($ MILLION)
TABLE 78 MIDDLE EAST & AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET BY INDICATION 2021–2027 (%)
TABLE 79 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 80 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 81 MAMMALIAN SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 82 MAMMALIAN SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 83 NON-MAMMALIAN SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021– 2027 ($ MILLION)
TABLE 84 NON-MAMMALIAN SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 85 COMMERCIAL SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 86 COMMERCIAL SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 87 RESEARCH SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 88 RESEARCH SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 89 FINISHED DOSAGE FORM SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 90 FINISHED DOSAGE FORM SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 91 ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 92 ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 93 ONCOLOGY SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 94 ONCOLOGY SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 95 BLOOD DISORDERS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 96 BLOOD DISORDERS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021– 2027 (%)
TABLE 97 INFLAMMATION & AUTOIMMUNE DISORDERS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 98 INFLAMMATION & AUTOIMMUNE DISORDERS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 99 OTHERS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 100 OTHERS SEGMENT IN BIOSIMILAR CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021–2027 (%)